75Pharma sets sights on the Nordics with expansion into Finland
6.10.2025
London, October 2025
Following its UK launch, 75Pharma is preparing to expand into Finland as the next step in its European growth strategy. The company develops high-quality pharmaceutical products and aims to combine therapeutic effectiveness with responsible business practices. Its planned entry into Finland will support broader Nordic growth ambitions and strengthen its presence within one of Europe’s most innovative healthcare regions.
Nordic Expansion: A Natural Next Step
With established operations in Helsinki, Stockholm and London, 75Pharma is well positioned to bring its approach to pharmaceutical products and responsible business practices to Nordic consumers who value transparency, trust and quality.
The Nordic region represents a natural next step in 75Pharma’s European growth strategy. As the company expands its presence across the region, it aims to bring its approach to high-quality products and responsible business practices to consumers who value transparency, trust and long-term value.
The planned expansion into Finland reflects 75Pharma’s ambition to build lasting partnerships and establish a strong foundation for future growth across the Nordic markets.
Building a growing impact movement in pharma
As part of its broader European growth strategy, 75Pharma is expanding its presence across the Nordics, beginning with the upcoming launch in Finland. The company’s goal is to replicate the success of its UK debut by forming partnerships with trusted retailers and distributors, ensuring its message and products reach conscious consumers throughout the region.
This next phase reinforces 75Pharma’s vision to lead a new era of impact-driven pharmaceuticals, where innovation, ethics, and sustainability define what modern healthcare can, and should be. 75Pharma will release Nordic launch timings separately.
Media & Partner Inquiries
75Pharma welcomes conversations with distributors, investors, healthcare providers, and media representatives as it enters the UK and Nordic markets.
• Sales & Distribution: sales@75pharmagroup.com
• Collaborations & Media Inquiries: pr@75pharmagroup.com
• Investor Relations: investorrelations@75pharmagroup.com
For more information, visit www.75pharmagroup.com
About 75Pharma
75Pharma is an impact company built to create lasting change for people and the planet. With operations in London, Stockholm, and Helsinki, the company offers premium pharmaceutical products designed for conscious consumers who seek both therapeutic effectiveness and the opportunity to support ethical business practices. Its launch in the UK marks a significant step toward building a more responsible and sustainable pharmaceutical future, with further expansion as a first step into the Nordics planned as part of its broader European growth strategy.
75Pharma – A way to feel better